InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Goldberg Mark Alan, 董事. Director active across 3 companies, notably Glycomimetics INC. In total, 17 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €270k. Activity tracked since 18 May 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Goldberg Mark Alan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
3,902 股Common StockSEC:0001104659-25-069384:0
3,902 股@ US$128.1261.7% 占其流量Common StockSEC:0001415889-25-018084:0
2,242 股0Common StockSEC:0001415889-24-016981:0
4,584 股@ US$3.0033.4% 占其流量Common StockSEC:0001415889-24-009744:0
60,720 股Common StockSEC:0001104659-24-014708:0
569 股@ US$29.657.6% 占其流量Common StockSEC:0001415889-24-000376:0
5,827 股@ US$2.3632.5% 占其流量Common stockSEC:0001209191-24-000067:0
10,000 股@ US$14.7069.1% 占其流量Common StockSEC:0001415889-23-014675:0
9,167 股@ US$1.5034.1% 占其流量Common stockSEC:0001209191-23-051449:0
1,063 股@ US$15.877.9% 占其流量Common StockSEC:0001415889-23-013757:0
894 股@ US$18.877.7% 占其流量Common StockSEC:0001415889-23-010821:0
2,600 股0Common StockSEC:0001415889-23-010263:0
4,394 股@ US$3.847.7% 占其流量Common StockSEC:0001415889-23-006057:0
2,600 股0Common StockSEC:0001415889-22-007131:0
5,000 股@ US$59.9838.3% 占其流量Common StockSEC:0001415889-22-002653:0
标准退出：2022年6月1日 (T+90)
2,250 股0Common StockSEC:0001179110-21-006420:0
5,250 股0Common StockSEC:0001209191-21-036378:0
17 条申报中的 17 条
About Goldberg Mark Alan
Mark Alan Goldberg is Administrateur of Blueprint Medicines Corp, ImmunoGen, Inc. and Glycomimetics INC. He has 17 filings, and across the 17 sampled filings the buy transactions amount to EUR 269880, with no sell transactions, covering the period from 2021-05-27 to 2025-07-21. The most frequent transaction nature is Attribution.
